As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of. As ...
"Weight loss medications are not one size fits all and patients should always discuss options with a trusted medical ...
A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...
If you’ve found yourself unexpectedly humming the tune “Magic” lately, you’re not alone. Thanks to the catchy commercial for ...
As a leading CGM maker, DexCom is likely to play a significant role in diabetes care for years, possibly decades. Given all ...
Recently, the spotlight on weight management and metabolic health has intensified, partly due to the rise of GLP-1 (glucagon-like peptide-1) medications like Ozempic and Wegovy. These drugs, ...
In the last couple of days at the European Association for the Study of Diabetes (EASD) 60th Annual Meeting 2024, the ...
A recent multinational, federated analysis of LEGEND-T2DM study published that Sodium-glucose cotransporter 2 inhibitors ...
Tirzepatide vs GLP-1 agonists demonstrated superior cardiorenal benefits among patients with type 2 diabetes. Treatment with tirzepatide, compared with glucagon-like peptide 1 (GLP-1) receptor ...
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...
Chinese pharmaceutical and biotech companies are leading development of glucagon-like peptide-1 receptor agonists as Novo Nordisk A/S and Eli Lilly and Co. edge closer to launching blockbuster ...
Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.